BRIEF-Tonix Pharmaceuticals Reports Q4 Loss Per Share Of $0.10

Reuters · 03/15/2021 20:57
BRIEF-Tonix Pharmaceuticals Reports Q4 Loss Per Share Of $0.10

- Tonix Pharmaceuticals Holding Corp TNXP.O:

  • TONIX PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

  • Q4 LOSS PER SHARE $0.10

  • TONIX PHARMACEUTICALS HOLDING - AT DECEMBER 31, 2020, CASH AND CASH EQUIVALENTS TOTALED $77.1 MILLION

  • PHASE 1 SAFETY STUDY IN HUMANS OF TNX-1800 EXPECTED TO START IN SECOND HALF 2021

Source text for Eikon: ID:nGNX7fBjDn

Further company coverage: TNXP.O


((Reuters.Briefs@thomsonreuters.com;))